株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Metabolic Solutions Development Company, LLC の製品パイプライン分析

Metabolic Solutions Development Company, LLC - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 318948
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: Global Markets Direct社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
Metabolic Solutions Development Company, LLC の製品パイプライン分析 Metabolic Solutions Development Company, LLC - Product Pipeline Review - 2014
出版日: 2014年11月14日 ページ情報: 英文 23 Pages
概要

Metabolic Solutions Development Company, LLC は代謝系疾患に対する分子標的の発見および治療薬の開発を行っている創薬企業です。パイプライン製品には経口インスリン増感剤、2型糖尿病患者のインスリン抵抗性治療薬等があります。

当レポートでは、Metabolic Solutions Development Company, LLC における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Metabolic Solutions Development Company, LLC の基本情報

  • Metabolic Solutions Development Company, LLC の概要
  • 主要情報
  • 企業情報

Metabolic Solutions Development Company, LLC :R&Dの概要

  • 主な治療範囲

Metabolic Solutions Development Company, LLC :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Metabolic Solutions Development Company, LLC :パイプライン製品の概況

  • 臨床段階にあるパイプライン製品
    • 第2相の製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階の製品/併用療法モダリティ
    • 創薬段階の製品/併用療法モダリティ

Metabolic Solutions Development Company, LLC :薬剤プロファイル

  • MSDC-0160
  • MSDC-0602
  • Small Molecules for Type-2 Diabetes

Metabolic Solutions Development Company, LLC :パイプライン分析

  • 投与経路別
  • 分子タイプ別

Metabolic Solutions Development Company, LLC :最新のパイプライン情報

Metabolic Solutions Development Company, LLC :本社と子会社の所在地

  • 本社

付録

図表一覧

目次
Product Code: GMDHC06504CDB

Summary

Global Markets Direct's, 'Metabolic Solutions Development Co. - Product Pipeline Review - 2014', provides an overview of the Metabolic Solutions Development Co.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Metabolic Solutions Development Co.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Metabolic Solutions Development Co. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Metabolic Solutions Development Co.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Metabolic Solutions Development Co.'s pipeline products

Reasons to buy

  • Evaluate Metabolic Solutions Development Co.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Metabolic Solutions Development Co. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Metabolic Solutions Development Co.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Metabolic Solutions Development Co. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Metabolic Solutions Development Co.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Metabolic Solutions Development Co. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Metabolic Solutions Development Company, LLC Snapshot
    • Metabolic Solutions Development Company, LLC Overview
    • Key Information
    • Key Facts
  • Metabolic Solutions Development Company, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Metabolic Solutions Development Company, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Metabolic Solutions Development Company, LLC - Pipeline Products Glance
    • Metabolic Solutions Development Company, LLC - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Metabolic Solutions Development Company, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Metabolic Solutions Development Company, LLC - Drug Profiles
    • MSDC-0160
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MSDC-0602
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Type-2 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Metabolic Solutions Development Company, LLC - Pipeline Analysis
    • Metabolic Solutions Development Company, LLC - Pipeline Products by Route of Administration
    • Metabolic Solutions Development Company, LLC - Pipeline Products by Molecule Type
  • Metabolic Solutions Development Company, LLC - Recent Pipeline Updates
  • Metabolic Solutions Development Company, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Metabolic Solutions Development Company, LLC, Key Information
  • Metabolic Solutions Development Company, LLC, Key Facts
  • Metabolic Solutions Development Company, LLC - Pipeline by Indication, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Stage of Development, 2014
  • Metabolic Solutions Development Company, LLC - Monotherapy Products in Pipeline, 2014
  • Metabolic Solutions Development Company, LLC - Phase II, 2014
  • Metabolic Solutions Development Company, LLC - Preclinical, 2014
  • Metabolic Solutions Development Company, LLC - Discovery, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Route of Administration, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Molecule Type, 2014
  • Metabolic Solutions Development Company, LLC - Recent Pipeline Updates, 2014

List of Figures

  • Metabolic Solutions Development Company, LLC - Pipeline by Top 10 Indication, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Stage of Development, 2014
  • Metabolic Solutions Development Company, LLC - Monotherapy Products in Pipeline, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Top 10 Route of Administration, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Top 10 Molecule Type, 2014
Back to Top